Softgel Manufacturing: A Global Growth Story

The global softgel capsules market continues to perform well with a recent valuation of $7.07 billion in 2023, rising to a forecasted $10.49 billion by 2030*.

Here at CAPTEK, we are excited by the opportunities in the softgel market. We believe that the factors driving growth are strong and sustainable, and that we look forward to supporting our customers in reaching their commercial goals.

Some of the main factors contributing to this growth are as follows –

Rising demand for pharmaceutical and nutraceutical products – softgels are a versatile dosage form that can be used to deliver a wide range of active ingredients, including vitamins, minerals, herbal extracts, and prescription drugs. As the global population ages and becomes more health-conscious, the demand for these products is expected to continue to grow.

Technological advancements in softgel manufacturing – recent advances in softgel manufacturing technology have made it possible to produce high-quality softgels more efficiently and cost-effectively. This has led to a wider range of softgel products becoming available at more affordable prices.

Softgels offer a number of advantages over other dosage forms, such as tablets and capsules. They are easier to swallow, have a better taste and odour profile, and offer superior bioavailability, driving consumer demand.

As a consequence, the main geographies for softgel manufacturing growth (Japan, Brazil, India, China, and the United States) are experiencing rapid growth in their pharmaceutical and nutraceutical industries, and are investing heavily in new softgel manufacturing technologies.

As a global business, we too are focused on innovation and investment in our solutions to support our customers’ goals. If you have a softgel machinery or equipment requirement, the team at CAPTEK would be happy to advise you.

info@capteksolutions.com

capteksolutions.com

 

*Source: Fortune Business Insights, 2023

Share this article: